Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 34 results for "zenotech"

Zenotech Laboratories reports standalone net loss of Rs 11.12 ...

Sales decline 15.71% to Rs 0.59 crore Net Loss of Zenotech Laboratories reported to Rs 11.12 crore in the quarter ended December 2014 as against net loss of Rs 6.87 crore during the previous quarter ended December 2013. Sales declined 15.71% to Rs 0.59 crore ... Business Standard, 1 month ago

Zenotech Laboratories to hold board meeting

will hold a meeting of the Board of Directors of the Company on 2 February 2015, to consider and approve the unaudited financial results of the Company for the quarter ended 31 December 2014Powered by Capital Market - Live News
 Business Standard1 month ago

Biosimilars of rituximab

Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is therefore used to treat diseases that are characterized by excessive number of ...
 GaBi Online1 week ago

Biosimilar and Follow-on Biologics Market - Global Forecast and Industry Outlook, 2012 to 2018

Transparency Market Research Report Added "Biosimilar and Follow-On Biologics Market" to its database. Albany, NY -- (ReleaseWire) -- 02/25/2015 -- There is a rising demand for low cost biological drugs. Commercial and regulatory developments are ...
 Digital Journal1 week ago

Biosimilar Monoclonal Antibodies: World Industry and Market Outlook 2015-2025

/PRNewswire/ -- Report Details Sponsored by: Biosimilar therapeutic antibodies - see why originator companies should now fear those competitors, discovering their trends and potential sales What's the future of biosimilar antibody therapies ...
 TickerTech.com3 weeks ago
[x]  

Divestment process for seven brands in progress for the Sun Pharma- Ranbaxy deal

The divestment process for seven brands of medicines is currently in progress as per the India's antitrust regulator Competition Commission of India (CCI) order for the Sun Pharma's USD 4-billion Ranbaxy deal, stated a Sun Pharma's official ...
 PharmaBiz3 weeks ago
India Infoline

Daily Market Strategy - Pushing down and pulling up on the Street

There are two ways of exerting one's strength: one is pushing down, the other is pulling up. - Booker T. Washington Any hopes of a fantastic Friday was dashed by the supply of paper in terms of Coal India OFS. Domestic institutions including LIC ...
 India Infoline1 month ago

Student Teams Race to Set 1000 mph Land Speed Record

Increasingly, making cars go faster falls under the purview of high-performance computing. This is especially true in the case of supersonic cars, vehicles capable of traveling faster than the speed of sound. With its undeniable cool factor and a ...
 HPC Wire1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less